The rare child who experiences relapsing TM typically either meets criteria for a diagnosis MS based on brain lesion pattern and non-spinal cord relapses or meets criteria for NMOSD (with antibodies to AQP4 or MOG). This evidence concerns the gene AQP4 and myeloid sarcoma.